Insider trades
Jonathan McNeill, COO of Crescent Biopharma CBIO, has filed 0 purchases and 31 sales on the open market. Over the past 12 months that comes to a net sale of $369.7K. The latest trade was on 06/22.
Jonathan McNeill
President and COO
- Company
- Crescent Biopharma CBIO
- First filing
- 23/01/11
- Trades
- 56 trades
- Buys / sales
- 0 / 31
- 12-month net buying
- −$369.7K
- Last trade
- 06/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/22 | 06/23 | 20,549 sh | $17.99 | $369,676.51 | −12.9% | |
DYN | Open-market sale10b5-1 plan | 24/08/19 | 24/08/20 | 2,705 sh2 trades | $45.12avg. | $122,054 | −2.0% |
| Open-market sale | 24/06/11 | 24/06/11 | 1,823 sh | $31.34 | $57,132.82 | −1.3% | |
DYN | Open-market sale10b5-1 plan | 24/05/16 | 24/05/17 | 2,774 sh2 trades | $28.27avg. | $78,419.85 | −2.0% |
DYN | Open-market sale10b5-1 plan | 24/03/08–24/03/11 | 24/03/13 | 109,601 sh5 trades | $26.11avg. | $2,861,373.09 | −44.0% |
| Open-market sale10b5-1 plan | 24/03/07 | 24/03/11 | 2,434 sh | $25.85 | $62,918.9 | −1.7% | |
DYN | Open-market sale10b5-1 plan | 24/02/29–24/03/01 | 24/03/01 | 28,528 sh4 trades | $28.46avg. | $811,865.05 | −16.6% |
DYN | Open-market sale10b5-1 plan | 24/01/26 | 24/01/26 | 20,000 sh2 trades | $24.53avg. | $490,510.36 | −12.2% |
DYN | Open-market sale10b5-1 plan | 24/01/02–24/01/04 | 24/01/04 | 31,900 sh4 trades | $16.59avg. | $529,194.3 | −18.2% |
| Open-market sale | 23/12/11 | 23/12/12 | 1,245 sh | $10.72 | $13,346.4 | −0.8% | |
| Open-market sale | 23/09/18 | 23/09/20 | 1,261 sh | $9.41 | $11,866.01 | −2.0% | |
| Open-market sale10b5-1 plan | 23/09/12 | 23/09/13 | 1,266 sh | $10.41 | $13,179.06 | −2.0% | |
DYN | Open-market sale10b5-1 plan | 23/06/12–23/06/13 | 23/06/14 | 2,259 sh2 trades | $12.68avg. | $28,649.37 | −3.5% |
DYN | Open-market sale | 23/03/13–23/03/14 | 23/03/15 | 2,209 sh2 trades | $13.18avg. | $29,115.97 | −3.3% |
| Open-market sale | 23/01/18 | 23/01/23 | 10,000 sh | $14.03 | $140,300 | −12.9% | |
| Open-market sale | 23/01/09 | 23/01/11 | 30,150 sh | $11.57 | $348,835.5 | −30.8% |
